Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) announced today that it will effect a reverse stock split of its outstanding shares of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE